Arwa Alghuneim
Papers
1
Total Citations
15
H-Index
1
About
Arwa Alghuneim is a pioneering researcher at the intersection of tissue engineering and oncology, specializing in the development of advanced three-dimensional disease models using bioprinting technologies. Her primary research focuses on creating biomimetic bone marrow microenvironments to study hematological malignancies, particularly acute myeloid leukemia (AML). Alghuneim’s most significant contribution is the fabrication of a three-dimensional bone marrow niche-like AML disease model through an automated, controlled process using robotic multicellular bioprinting—a breakthrough that addresses the critical need for robust preclinical platforms to investigate therapy resistance and disease relapse. Her work, published in 2023 and garnering 15 citations, demonstrates how engineering complex tissue architectures can recapitulate the cellular and extracellular cues of the bone marrow, enabling more accurate drug testing and mechanistic studies. By integrating automation with multicellular printing, she has established a reproducible system that reduces variability and enhances translational relevance. Alghuneim’s innovative approach bridges biofabrication and cancer biology, offering new avenues for personalized medicine and targeted therapies. Her achievements highlight her as a rising leader in the field of disease modeling and regenerative medicine.
Research Focus
Key Achievements
Top Papers
- 1